Botta M - Search Results

1

Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria.

Laschi M, Bernardini G, Dreassi E, Millucci L, Geminiani M, Braconi D, Marzocchi B, Botta M, Manetti F, Santucci A. Laschi M, et al. Among authors: botta m. ChemMedChem. 2016 Apr 5;11(7):674-8. doi: 10.1002/cmdc.201500578. Epub 2016 Mar 7. ChemMedChem. 2016. PMID: 26947423

2

Small-molecule inhibitors of fibroblast growth factor receptor (FGFR) tyrosine kinases (TK).

Manetti F, Botta M. Manetti F, et al. Among authors: botta m. Curr Pharm Des. 2003;9(7):567-81. doi: 10.2174/1381612033391487. Curr Pharm Des. 2003. PMID: 12570804 Review.

3

Inhibition of Bcr-Abl phosphorylation and induction of apoptosis by pyrazolo[3,4-d]pyrimidines in human leukemia cells.

Manetti F, Pucci A, Magnani M, Locatelli GA, Brullo C, Naldini A, Schenone S, Maga G, Carraro F, Botta M. Manetti F, et al. Among authors: botta m. ChemMedChem. 2007 Mar;2(3):343-53. doi: 10.1002/cmdc.200600214. ChemMedChem. 2007. PMID: 17295370

4

C6-unsubstituted pyrazolo[3,4-d]pyrimidines are dual Src/Abl inhibitors effective against imatinib mesylate resistant chronic myeloid leukemia cell lines.

Santucci MA, Corradi V, Mancini M, Manetti F, Radi M, Schenone S, Botta M. Santucci MA, et al. Among authors: botta m. ChemMedChem. 2009 Jan;4(1):118-26. doi: 10.1002/cmdc.200800320. ChemMedChem. 2009. PMID: 19039816

5

3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors.

Falchi F, Manetti F, Carraro F, Naldini A, Maga G, Crespan E, Schenone S, Bruno O, Brullo C, Botta M. Falchi F, et al. Among authors: botta m. ChemMedChem. 2009 Jun;4(6):976-87. doi: 10.1002/cmdc.200800441. ChemMedChem. 2009. PMID: 19326384

6

Evaluation of novel epothilone analogues by means of a common pharmacophore and a QSAR pseudoreceptor model for taxanes and epothilones.

Forli S, Manetti F, Altmann KH, Botta M. Forli S, et al. Among authors: botta m. ChemMedChem. 2010 Jan;5(1):35-40. doi: 10.1002/cmdc.200900303. ChemMedChem. 2010. PMID: 19904799 No abstract available.

7

Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach.

Biava M, Porretta GC, Poce G, Battilocchio C, Alfonso S, de Logu A, Manetti F, Botta M. Biava M, et al. Among authors: botta m. ChemMedChem. 2011 Apr 4;6(4):593-9. doi: 10.1002/cmdc.201000526. Epub 2011 Feb 21. ChemMedChem. 2011. PMID: 21341373 Review.

8

Targeting protein-protein and protein-nucleic acid interactions for anti-HIV therapy.

Mori M, Manetti F, Botta M. Mori M, et al. Among authors: botta m. Curr Pharm Des. 2011 Nov;17(33):3713-28. doi: 10.2174/138161211798220972. Curr Pharm Des. 2011. PMID: 21875413 Review.

9

Differentially activated Src kinase in chemo-naïve human primary osteosarcoma cells and effects of a Src kinase inhibitor.

Laschi M, Bernardini G, Geminiani M, Manetti F, Mori M, Spreafico A, Campanacci D, Capanna R, Schenone S, Botta M, Santucci A. Laschi M, et al. Among authors: botta m. Biofactors. 2017 Nov;43(6):801-811. doi: 10.1002/biof.1382. Epub 2017 Aug 8. Biofactors. 2017. PMID: 28786551

10

3D QSAR models of interactions between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA): a survey on taxanes and epothilones.

Manetti F, Maccari L, Corelli F, Botta M. Manetti F, et al. Among authors: botta m. Curr Top Med Chem. 2004;4(2):203-17. doi: 10.2174/1568026043451465. Curr Top Med Chem. 2004. PMID: 14754454 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

731 results

Search Page

Filters